Pharma excessive pricing probe spreads to South Africa
Credit: iStock.com/zozzzzo
South Africa’s antitrust enforcer has opened wide-ranging investigations of Roche, Pfizer and Aspen, accusing the pharmaceutical companies of illegal unilateral conduct affecting the price and availability of cancer drugs.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now